Publications by authors named "Christina von Gugelberg"
Br J Dermatol
August 2024
Article Synopsis
- Mycosis fungoides (MF) and Sézary syndrome (SS) are chronic skin cancers that require various treatment strategies; interferon-α (IFN-α) has been used for years, but only the pegylated form, PEG-IFN-α-2a, remains available, though not officially approved for these conditions.
- A study involving 105 patients across 10 countries assessed the effectiveness and safety of PEG-IFN-α-2a, focusing on the time to next treatment (TTNT) as a measure of its clinical benefit.
- Results showed a 53.3% overall response rate with better TTNT for patients receiving combination therapy (10.4 months) compared
